Gritstone bio, Inc.
At Close: 4:00 PM
Pre Market: 7:54 AM
GRTS Stock Price Graph
GRTS Stock Price Today
Gritstone bio, Inc. (GRTS) stock declined over -6.42% intraday to trade at $2.48 a share on NASDAQ. The stock opened with a loss of -1.13% at $2.62 and touched an intraday high of $2.75, falling -6.42% against the last close of $2.65. The Gritstone bio, Inc. in stock market went to a low of $2.48 during the session.
GRTS Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
5959 Horton Street
EmeryVille, CA 94608
Contact #:510 871 6100
Sales or Revenue$18.75 Million
5Y Sales Change-
Fiscal Year EndsDec. 2021
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Frequently Asked Questions
What is the current Gritstone bio, Inc. (GRTS) stock price?
Gritstone bio, Inc. (NASDAQ: GRTS) stock price is $2.48 in the last trading session. During the trading session, GRTS stock reached the peak price of $2.75 while $2.48 was the lowest point it dropped to. The percentage change in GRTS stock occurred in the recent session was -6.42% while the dollar amount for the price change in GRTS stock was -$0.17.
GRTS's industry and sector of operation?
The NASDAQ listed GRTS is part of Biotechnology industry that operates in the broader Health Care sector. Gritstone bio, Inc. , a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases.
Who are the executives of GRTS?
Dr. Matthew Hawryluk
Executive Vice President & Chief Bus. Officer
Ms. Stacy Proctor
Senior Vice President & Head of People
Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.
Co-Founder, Pres, Chief Executive Officer & Director
Dr. Karin Jooss Ph.D.
Executive Vice President and Head of R&D
How GRTS did perform over past 52-week?
GRTS's closing price is 0.45% higher than its 52-week low of $1.71 where as its distance from 52-week high of $5.85 is -0.58%.
How many employees does GRTS have?
Number of GRTS employees currently stands at 233. GRTS operates from 5959 Horton Street, Suite 300, EmeryVille, CA 94608, United States.
Link for GRTS official website?
Official Website of GRTS is: https://gritstonebio.com
How do I contact GRTS?
GRTS could be contacted at phone #510 871 6100 and can also be accessed through its website. GRTS operates from 5959 Horton Street, Suite 300, EmeryVille, CA 94608, United States.
How many shares of GRTS are traded daily?
GRTS stock volume for the day was 386,111 shares. The average number of GRTS shares traded daily for last 3 months was 801.02 Thousands.
What is the market cap of GRTS currently?
The market value of GRTS currently stands at $241.57 Million with its latest stock price at $2.48 and 86.89 Million of its shares outstanding.